ASH Annual Conference to showcase latest treatments and research for blood disorders The American Culture of Hematology , the world’s largest professional association of blood specialists, expects more than 20,000 attendees at the 51st ASH Annual Conference from December 5-8, 2009, at the Ernest N. Morial Convention Center in New Orleans, LA UAE pharmacy . The meeting will showcase the most recent research and remedies for blood disorders. ‘It is my satisfaction to host ASH’s 51st annual meeting, where we will celebrate the beginning of the ‘next 50 years’ of ASH with an revise on continuing improvements in hematology,’ stated Nancy Berliner, MD, 2009 ASH President, and Chief of Hematology at Brigham and Women’s Hospital in Boston and a Professor of Medicine at Harvard Medical College.
Regarding specific medication classes, there was a substantial 36 percent annual increase in NNRTI resistance since the ART rollout in east Africa and a 23 percent annual upsurge in southern Africa. In east Africa, the estimated prevalence of NNRTI level of resistance was 5.1 percent 8 years following the rollout. ‘Although still within anticipated levels, further boosts in the prevalence of HIV drug level of resistance may jeopardize the global HIV response, ‘ write Bertagnolio and colleagues. Further raises would halt the decade-long pattern of decreasing HIV-related morbidity and mortality in low-income countries, they add. In an editorial, Douglas Richman points out that the price and restricted usage of second-range treatment regimens in resource-limited countries would diminish the ability to manage obtained and transmitted medication resistance.